Annual EBITDA:
$1.39B+$88.72M(+6.84%)Summary
- As of today, JAZZ annual EBITDA is $1.39 billion, with the most recent change of +$88.72 million (+6.84%) on December 31, 2024.
- During the last 3 years, JAZZ annual EBITDA has risen by +$434.94 million (+45.70%).
- JAZZ annual EBITDA is now at all-time high.
Performance
JAZZ EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$339.75M-$53.22M(-13.54%)Summary
- As of today, JAZZ quarterly EBITDA is $339.75 million, with the most recent change of -$53.22 million (-13.54%) on September 30, 2025.
- Over the past year, JAZZ quarterly EBITDA has dropped by -$85.69 million (-20.14%).
- JAZZ quarterly EBITDA is now -20.14% below its all-time high of $425.44 million, reached on September 30, 2024.
Performance
JAZZ Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$1.20B-$85.69M(-6.66%)Summary
- As of today, JAZZ TTM EBITDA is $1.20 billion, with the most recent change of -$85.69 million (-6.66%) on September 30, 2025.
- Over the past year, JAZZ TTM EBITDA has dropped by -$188.03 million (-13.54%).
- JAZZ TTM EBITDA is now -13.54% below its all-time high of $1.39 billion, reached on September 30, 2024.
Performance
JAZZ TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
JAZZ EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +6.8% | -20.1% | -13.5% |
| 3Y3 Years | +45.7% | +11.2% | +2.1% |
| 5Y5 Years | +37.0% | +22.4% | +19.9% |
JAZZ EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +45.7% | -20.1% | +211.8% | -13.5% | +3.2% |
| 5Y | 5-Year | at high | +45.7% | -20.1% | +211.8% | -13.5% | +27.3% |
| All-Time | All-Time | at high | +1235.9% | -20.1% | +405.4% | -13.5% | +823.7% |
JAZZ EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $339.75M(-13.5%) | $1.20B(-6.7%) |
| Jun 2025 | - | $392.98M(+260.6%) | $1.29B(+2.4%) |
| Mar 2025 | - | $108.98M(-69.7%) | $1.26B(-9.4%) |
| Dec 2024 | $1.39B(+6.8%) | $359.19M(-15.6%) | $1.39B(-0.2%) |
| Sep 2024 | - | $425.44M(+17.4%) | $1.39B(+7.0%) |
| Jun 2024 | - | $362.48M(+51.3%) | $1.30B(+3.6%) |
| Mar 2024 | - | $239.59M(-33.7%) | $1.25B(-3.5%) |
| Dec 2023 | $1.30B(-3.8%) | $361.43M(+7.9%) | $1.30B(+8.8%) |
| Sep 2023 | - | $334.95M(+5.6%) | $1.19B(+2.5%) |
| Jun 2023 | - | $317.21M(+11.5%) | $1.16B(-2.9%) |
| Mar 2023 | - | $284.42M(+11.0%) | $1.20B(+1.5%) |
| Dec 2022 | $1.35B(+41.8%) | $256.35M(-16.1%) | $1.18B(+0.4%) |
| Sep 2022 | - | $305.68M(-13.1%) | $1.18B(+5.0%) |
| Jun 2022 | - | $351.71M(+31.6%) | $1.12B(+14.8%) |
| Mar 2022 | - | $267.26M(+6.1%) | $975.63M(+3.4%) |
| Dec 2021 | $951.76M(-8.8%) | $251.80M(+1.0%) | $943.46M(-3.0%) |
| Sep 2021 | - | $249.35M(+20.3%) | $972.75M(-2.8%) |
| Jun 2021 | - | $207.22M(-11.9%) | $1.00B(-5.8%) |
| Mar 2021 | - | $235.09M(-16.4%) | $1.06B(+1.8%) |
| Dec 2020 | $1.04B(+3.1%) | $281.09M(+1.2%) | $1.04B(+4.2%) |
| Sep 2020 | - | $277.70M(+3.3%) | $1.00B(+2.7%) |
| Jun 2020 | - | $268.84M(+24.4%) | $975.85M(-0.3%) |
| Mar 2020 | - | $216.09M(-9.7%) | $978.43M(-3.4%) |
| Dec 2019 | $1.01B(+15.7%) | $239.19M(-5.0%) | $1.01B(+0.4%) |
| Sep 2019 | - | $251.73M(-7.3%) | $1.01B(+1.2%) |
| Jun 2019 | - | $271.41M(+8.5%) | $996.72M(+1.7%) |
| Mar 2019 | - | $250.17M(+6.2%) | $980.10M(+12.1%) |
| Dec 2018 | $874.97M(+12.3%) | $235.47M(-1.8%) | $874.47M(+3.5%) |
| Sep 2018 | - | $239.67M(-5.9%) | $844.90M(+3.4%) |
| Jun 2018 | - | $254.79M(+76.3%) | $817.06M(+7.7%) |
| Mar 2018 | - | $144.54M(-29.8%) | $758.60M(-2.6%) |
| Dec 2017 | $779.00M(+5.2%) | $205.91M(-2.8%) | $779.00M(+0.1%) |
| Sep 2017 | - | $211.83M(+7.9%) | $778.36M(+4.1%) |
| Jun 2017 | - | $196.32M(+19.0%) | $747.35M(-0.2%) |
| Mar 2017 | - | $164.94M(-19.6%) | $749.02M(+1.3%) |
| Dec 2016 | $740.68M(+14.0%) | $205.27M(+13.5%) | $739.16M(+5.7%) |
| Sep 2016 | - | $180.83M(-8.7%) | $699.58M(+3.0%) |
| Jun 2016 | - | $197.99M(+27.7%) | $678.96M(+2.8%) |
| Mar 2016 | - | $155.08M(-6.4%) | $660.30M(+1.6%) |
| Dec 2015 | $649.64M | $165.68M(+3.4%) | $649.79M(-0.8%) |
| Sep 2015 | - | $160.21M(-10.7%) | $655.26M(-0.9%) |
| Jun 2015 | - | $179.33M(+24.0%) | $660.88M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $144.58M(-15.5%) | $626.60M(+7.1%) |
| Dec 2014 | $590.50M(+32.6%) | $171.14M(+3.2%) | $584.86M(+9.0%) |
| Sep 2014 | - | $165.83M(+14.3%) | $536.42M(+8.0%) |
| Jun 2014 | - | $145.05M(+41.1%) | $496.72M(+9.6%) |
| Mar 2014 | - | $102.83M(-16.2%) | $453.34M(+1.5%) |
| Dec 2013 | $445.30M(+40.3%) | $122.70M(-2.7%) | $446.84M(+3.8%) |
| Sep 2013 | - | $126.13M(+24.0%) | $430.47M(+12.8%) |
| Jun 2013 | - | $101.68M(+5.5%) | $381.66M(+15.2%) |
| Mar 2013 | - | $96.33M(-9.4%) | $331.42M(+16.5%) |
| Dec 2012 | $317.48M(+116.2%) | $106.33M(+37.5%) | $284.37M(+27.6%) |
| Sep 2012 | - | $77.32M(+50.3%) | $222.88M(+19.1%) |
| Jun 2012 | - | $51.44M(+4.4%) | $187.21M(+9.1%) |
| Mar 2012 | - | $49.28M(+9.9%) | $171.59M(+16.8%) |
| Dec 2011 | $146.86M(+120.8%) | $44.84M(+7.7%) | $146.88M(+13.3%) |
| Sep 2011 | - | $41.65M(+16.2%) | $129.61M(+24.1%) |
| Jun 2011 | - | $35.83M(+45.8%) | $104.46M(+28.2%) |
| Mar 2011 | - | $24.57M(-10.9%) | $81.48M(+22.5%) |
| Dec 2010 | $66.50M(+165.7%) | $27.57M(+67.2%) | $66.50M(+26.1%) |
| Sep 2010 | - | $16.49M(+28.4%) | $52.72M(+24.5%) |
| Jun 2010 | - | $12.85M(+34.0%) | $42.36M(+6.6%) |
| Mar 2010 | - | $9.59M(-30.5%) | $39.73M(+58.8%) |
| Dec 2009 | $25.03M(+120.5%) | $13.79M(+125.0%) | $25.03M(+750.2%) |
| Sep 2009 | - | $6.13M(-40.0%) | -$3.85M(+88.6%) |
| Jun 2009 | - | $10.22M(+299.7%) | -$33.65M(+60.9%) |
| Mar 2009 | - | -$5.12M(+66.0%) | -$86.03M(+29.5%) |
| Dec 2008 | -$122.08M(-34.7%) | -$15.08M(+36.3%) | -$122.08M(+14.6%) |
| Sep 2008 | - | -$23.67M(+43.8%) | -$142.91M(-6.3%) |
| Jun 2008 | - | -$42.16M(-2.4%) | -$134.41M(-17.0%) |
| Mar 2008 | - | -$41.16M(-14.6%) | -$114.93M(-26.8%) |
| Dec 2007 | -$90.62M(-33.8%) | -$35.91M(-136.6%) | -$90.62M(+45.4%) |
| Sep 2007 | - | -$15.18M(+33.0%) | -$165.94M(-19.3%) |
| Jun 2007 | - | -$22.67M(-34.5%) | -$139.09M(-32.8%) |
| Mar 2007 | - | -$16.86M(+84.8%) | -$104.75M(-34.2%) |
| Dec 2006 | -$67.74M(-31.0%) | -$111.23M(-1052.9%) | -$78.05M(-94.9%) |
| Sep 2006 | - | $11.67M(0.0%) | -$40.04M(+13.6%) |
| Jun 2006 | - | $11.67M(+18.7%) | -$46.35M(+12.0%) |
| Mar 2006 | - | $9.84M(+113.4%) | -$52.67M(+7.8%) |
| Dec 2005 | -$51.70M(-104.2%) | -$73.23M(-1465.9%) | -$57.14M(-455.3%) |
| Sep 2005 | - | $5.36M(0.0%) | $16.08M(+50.0%) |
| Jun 2005 | - | $5.36M(0.0%) | $10.72M(+100.0%) |
| Mar 2005 | - | $5.36M | $5.36M |
| Dec 2004 | -$25.32M | - | - |
FAQ
- What is Jazz Pharmaceuticals plc annual EBITDA?
- What is the all-time high annual EBITDA for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc annual EBITDA year-on-year change?
- What is Jazz Pharmaceuticals plc quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc quarterly EBITDA year-on-year change?
- What is Jazz Pharmaceuticals plc TTM EBITDA?
- What is the all-time high TTM EBITDA for Jazz Pharmaceuticals plc?
- What is Jazz Pharmaceuticals plc TTM EBITDA year-on-year change?
What is Jazz Pharmaceuticals plc annual EBITDA?
The current annual EBITDA of JAZZ is $1.39B
What is the all-time high annual EBITDA for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high annual EBITDA is $1.39B
What is Jazz Pharmaceuticals plc annual EBITDA year-on-year change?
Over the past year, JAZZ annual EBITDA has changed by +$88.72M (+6.84%)
What is Jazz Pharmaceuticals plc quarterly EBITDA?
The current quarterly EBITDA of JAZZ is $339.75M
What is the all-time high quarterly EBITDA for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high quarterly EBITDA is $425.44M
What is Jazz Pharmaceuticals plc quarterly EBITDA year-on-year change?
Over the past year, JAZZ quarterly EBITDA has changed by -$85.69M (-20.14%)
What is Jazz Pharmaceuticals plc TTM EBITDA?
The current TTM EBITDA of JAZZ is $1.20B
What is the all-time high TTM EBITDA for Jazz Pharmaceuticals plc?
Jazz Pharmaceuticals plc all-time high TTM EBITDA is $1.39B
What is Jazz Pharmaceuticals plc TTM EBITDA year-on-year change?
Over the past year, JAZZ TTM EBITDA has changed by -$188.03M (-13.54%)